QIFENG
873169
LEETRO
430425
KSEC Intelligent Technology
301311
4
Guangdong Topstar Technology
300607
5
Hengerda New Materials
300946
CN Stock MarketDetailed Quotes
688278 Xiamen Amoytop Biotech
- 74.49
- +0.66+0.89%
Market Closed May 12 15:00 CST
30.30BMarket Cap34.39P/E (TTM)
74.60High72.50Low24.61KlotVolume73.88Open73.83Pre Close181.76MTurnover0.61%Turnover Ratio36.62P/E (Static)406.80MShares87.7652wk High12.14P/B30.30BFloat Cap45.6852wk Low88.60Limit Up406.80MShs Float87.76Historical High59.06Limit Down2.84%Amplitude19.98Historical Low0.62Dividend TTM73.85Avg Price9.00KlotAsk0.83%Div YieldTTM100Lot Size13.90KlotBid
Xiamen Amoytop Biotech Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -19.42%528.07M | -9.96%371.82M | -36.61%333.25M | -10.24%284.9M | 25.85%655.38M | 37.09%412.96M | 56.32%525.69M | -21.39%317.42M | 5.91%520.78M | 5.54%301.24M |
| Transactional financial assets | --290.04M | 12.79%289.96M | 128.11%251.29M | 364.56%139.87M | ---- | -5.06%257.08M | -27.14%110.16M | -66.72%30.11M | ---- | 37.88%270.78M |
| Notes receivable and accounts receivable | 74.87%695.96M | 83.33%808.52M | 99.05%577.91M | 51.25%531.7M | 46.14%397.99M | 97.73%441.02M | 21.67%290.34M | 67.80%351.54M | 42.17%272.33M | 8.13%223.05M |
| -Notes receivable | 1,198.23%41.94M | 1,052.92%37.03M | 2,874.05%27.06M | 3,853.96%70.73M | 16.73%3.23M | -46.13%3.21M | -84.78%909.85K | -79.67%1.79M | -67.48%2.77M | -70.05%5.96M |
| -Accounts receivable | 65.68%654.02M | 76.22%771.5M | 90.33%550.85M | 31.80%460.97M | 46.44%394.76M | 101.68%437.81M | 24.41%289.43M | 74.27%349.76M | 47.27%269.56M | 16.48%217.09M |
| Other receivables (including interest and dividends) | -3.25%30.75M | 23.46%21.98M | -0.83%35.87M | 99.23%31.67M | 160.72%31.78M | -11.55%17.8M | 107.63%36.17M | -11.53%15.89M | -41.16%12.19M | -6.83%20.13M |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | --87.74K | ---- | ---- | ---- |
| -Other receivable | ---- | 23.46%21.98M | ---- | 99.23%31.67M | ---- | -11.55%17.8M | ---- | -11.53%15.89M | ---- | -6.83%20.13M |
| Advance payment | 65.93%57.04M | 65.75%38.77M | 114.11%56.88M | 102.28%64.07M | 113.34%34.38M | 161.37%23.39M | 34.88%26.57M | 118.54%31.67M | 19.31%16.11M | 29.28%8.95M |
| Inventories | 32.10%285.46M | 40.92%263.55M | 47.55%252.75M | 50.18%230.11M | 54.56%216.1M | 44.16%187.02M | 42.42%171.3M | 23.94%153.22M | 18.02%139.81M | 11.36%129.73M |
| Non-current assets due within one year | --30.74M | --30.74M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 101.30%1.97M | 89.30%1.75M | 317.69%1.59M | 649.86%1.34M | 300.28%976.51K | -46.89%923.79K | 88.62%379.98K | 92.91%178.6K | -74.72%243.96K | 30.49%1.74M |
| Total current assets | 43.65%1.92B | 36.33%1.83B | 30.07%1.51B | 42.62%1.28B | 39.02%1.34B | 40.24%1.34B | 31.34%1.16B | 4.66%900.04M | 12.20%961.47M | 14.52%955.61M |
| Non Current assets | ||||||||||
| Other non-current financial assets | 7.38%56.76M | 51.97%56.76M | 65.82%58.04M | 65.81%58.04M | 51.04%52.86M | --37.35M | --35M | --35M | --35M | ---- |
| Fixed assets | ---- | 66.20%496.53M | ---- | 15.44%316.1M | ---- | 22.44%298.75M | ---- | 90.63%273.82M | ---- | 300.27%244M |
| Constru in process | ---- | -1.17%181.56M | ---- | 102.74%259.97M | ---- | 35.27%183.72M | ---- | 39.03%128.23M | ---- | 15.10%135.81M |
| Intangible assets | -10.96%162.62M | -10.80%170.85M | -9.47%179.07M | 58.21%173.83M | 58.36%182.64M | 57.40%191.54M | 54.51%197.81M | -18.16%109.87M | -17.89%115.33M | -17.16%121.69M |
| Development expenditure | 26.67%219.33M | 29.66%208.89M | -12.48%192.88M | -40.97%183.18M | -31.50%173.16M | -26.90%161.11M | 2.76%220.38M | 58.16%310.3M | 37.84%252.79M | 35.38%220.39M |
| Long deferred expense | 1.85%16.7M | -21.06%12.31M | -8.55%17.76M | 114.52%19.37M | 115.63%16.39M | 76.05%15.59M | 271.54%19.42M | 64.99%9.03M | 29.21%7.6M | 39.67%8.86M |
| Deferred tax assets | 65.69%67.15M | 58.24%69.09M | 0.27%42.98M | -1.45%43.88M | -8.30%40.53M | -7.46%43.66M | 4.49%42.86M | 19.82%44.53M | 13.75%44.2M | 34.96%47.18M |
| Usufruct assets | -1.54%8.02M | 3.40%8.67M | -1.22%9.72M | -1.78%10.56M | -12.87%8.15M | -15.78%8.39M | -5.08%9.84M | -0.05%10.75M | -25.62%9.35M | -28.68%9.96M |
| Other non current assets | -75.17%17.14M | -75.37%18.67M | -9.88%46.51M | 32.96%56.17M | 79.03%69.05M | 187.37%75.79M | -4.87%51.61M | -22.69%42.25M | -33.18%38.57M | -42.45%26.37M |
| Total non current assets | 15.48%1.26B | 20.42%1.22B | 20.18%1.17B | 16.32%1.12B | 23.40%1.09B | 24.76%1.02B | 32.89%976.69M | 42.92%963.78M | 39.25%883.53M | 38.07%814.26M |
| Total assets | 30.99%3.18B | 29.47%3.05B | 25.55%2.68B | 29.02%2.4B | 31.54%2.43B | 33.12%2.36B | 32.04%2.14B | 21.48%1.86B | 23.71%1.85B | 24.27%1.77B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --9.87M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Notes payable and accounts payable | 29.77%56.85M | 48.04%60.14M | 64.30%56.36M | -48.60%30.65M | -54.71%43.81M | -58.27%40.62M | 5.63%34.3M | 18.51%59.63M | 80.85%96.74M | 147.84%97.35M |
| -Accounts payable | 29.77%56.85M | 48.04%60.14M | 64.30%56.36M | -48.60%30.65M | -54.71%43.81M | -58.27%40.62M | 5.63%34.3M | 18.51%59.63M | 80.85%96.74M | 147.84%97.35M |
| Contract liabilities | -7.96%62.19M | 5.12%63.13M | 4.28%62.14M | 106.05%68.74M | 1,317.10%67.57M | 730.32%60.05M | 1,388.11%59.59M | 548.09%33.36M | 7.29%4.77M | 39.51%7.23M |
| Salaries payable | -2.45%128.56M | -9.48%178.48M | -23.76%131.3M | 50.94%133.59M | 95.25%131.79M | 99.31%197.17M | 98.42%172.23M | 36.53%88.5M | 23.82%67.5M | 38.96%98.93M |
| Taxs payable | -16.90%43.56M | 7.18%69.76M | -3.40%56.12M | 14.85%42.48M | -10.61%52.41M | 28.71%65.09M | 17.60%58.09M | 3.34%36.99M | 54.56%58.63M | 65.77%50.57M |
| Other payable (including interest and dividends) | -17.05%39.29M | 18.99%43.33M | 153.18%38.81M | 66.12%34.99M | 57.48%47.37M | 286.59%36.41M | -56.79%15.33M | -14.67%21.06M | 38.01%30.08M | -37.72%9.42M |
| -Other payable | ---- | 18.99%43.33M | ---- | 66.12%34.99M | ---- | 286.59%36.41M | ---- | -14.67%21.06M | ---- | -37.72%9.42M |
| Non current liabilities due within one year | 11.51%5.05M | 36.15%5.67M | -13.31%4.45M | -20.35%4.33M | 531.03%4.52M | -0.34%4.16M | 33.27%5.14M | 26.65%5.44M | -119.01%-1.05M | -27.85%4.18M |
| Other current liabilities | -6.40%144.36K | -13.53%123.39K | 72.56%126.73K | 53.55%247.51K | 7.83%154.24K | -34.24%142.69K | -38.86%73.44K | 4.96%161.19K | 14.23%143.04K | 39.51%216.98K |
| Total current liabilities | -0.61%345.5M | 4.20%420.63M | 1.32%349.3M | 28.51%315.02M | 35.37%347.63M | 50.68%403.66M | 62.52%344.75M | 25.58%245.13M | 36.73%256.8M | 51.16%267.89M |
| Current liabilities | ||||||||||
| Estimate liabilities | 26.19%39.65M | 25.79%39.31M | -21.93%28.63M | 10.89%31.78M | 20.65%31.42M | 20.24%31.25M | 51.62%36.68M | 37.40%28.66M | 32.92%26.04M | 33.04%25.99M |
| Deferred tax liabilities | 52.05%877.21K | 130.54%933.81K | -94.37%913.65K | -96.41%549.93K | -95.69%576.91K | -97.33%405.06K | 129.26%16.23M | 119.24%15.3M | 99.98%13.39M | 173.69%15.15M |
| Long term deferred income | 3.77%40.56M | -18.85%32.96M | -24.12%34.47M | -18.62%37.57M | -16.73%39.08M | -14.82%40.62M | -4.57%45.42M | -6.88%46.17M | -6.92%46.94M | -6.95%47.68M |
| Lease liabilities | 8.54%3.26M | -13.10%3.27M | 25.00%5.45M | 8.09%5.87M | -70.17%3M | -32.42%3.76M | -34.62%4.36M | -27.07%5.43M | 23.15%10.06M | -40.64%5.56M |
| Total non current liabilities | 13.85%84.34M | 0.58%76.47M | -32.35%69.47M | -20.71%75.77M | -23.18%74.08M | -19.45%76.03M | 20.05%102.69M | 12.60%95.56M | 13.60%96.43M | 10.15%94.38M |
| Total liabilities | 1.93%429.84M | 3.63%497.1M | -6.41%418.77M | 14.70%390.79M | 19.38%421.7M | 32.41%479.69M | 50.32%447.44M | 21.65%340.7M | 29.53%353.23M | 37.79%362.27M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M | 0.00%406.8M |
| Capital reserve funds | 7.54%426.98M | 4.06%413.14M | 0.20%397.82M | 0.00%397.04M | 0.00%397.04M | 0.00%397.04M | 0.00%397.04M | 0.00%397.04M | 0.00%397.04M | 0.00%397.04M |
| Surplus reserve funds | 55.64%182.95M | 55.64%182.95M | 61.11%117.55M | 61.11%117.55M | 61.11%117.55M | 61.11%117.55M | 59.83%72.96M | 59.83%72.96M | 59.83%72.96M | 59.83%72.96M |
| Retained profit | 59.86%1.73B | 62.35%1.55B | 65.10%1.34B | 69.04%1.09B | 76.24%1.08B | 79.92%955.01M | 72.44%813.06M | 59.69%646.33M | 66.56%614.97M | 70.25%530.8M |
| Shareholders equity without minority interests | 37.11%2.75B | 36.08%2.55B | 34.01%2.26B | 32.22%2.01B | 34.42%2.01B | 33.30%1.88B | 27.92%1.69B | 21.44%1.52B | 22.41%1.49B | 21.21%1.41B |
| Total shareholder equity | 37.11%2.75B | 36.08%2.55B | 34.01%2.26B | 32.22%2.01B | 34.42%2.01B | 33.30%1.88B | 27.92%1.69B | 21.44%1.52B | 22.41%1.49B | 21.21%1.41B |
| Total liabilityies and equity | 30.99%3.18B | 29.47%3.05B | 25.55%2.68B | 29.02%2.4B | 31.54%2.43B | 33.12%2.36B | 32.04%2.14B | 21.48%1.86B | 23.71%1.85B | 24.27%1.77B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.